High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation

Raphaël Decoin, Laura Butruille, Thomas Defrancq, Jordan Robert, Nicolas Destrait, Augustin Coisne, Samy Aghezzaf, Eloise Woitrain, Zouriatou Gouda, Sofia Schino, Cédric Klein, Patrice Maboudou, François Brigadeau, Didier Klug, Andre Vincentelli, David Dombrowicz, Bart Staels, David Montaigne, Sandro Ninni

Open source

DOI: 10.3389/fendo.2022.957245
Published: 2022-08-31
Container: Frontiers in Endocrinology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2022.957245,
  title = {High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation},
  author = {Raphaël Decoin and Laura Butruille and Thomas Defrancq and Jordan Robert and Nicolas Destrait and Augustin Coisne and Samy Aghezzaf and Eloise Woitrain and Zouriatou Gouda and Sofia Schino and Cédric Klein and Patrice Maboudou and François Brigadeau and Didier Klug and Andre Vincentelli and David Dombrowicz and Bart Staels and David Montaigne and Sandro Ninni},
  year = {2022},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2022.957245},
  url = {https://doi.org/10.3389/fendo.2022.957245}
}

RIS

TY  - JOUR
TI  - High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
AU  - Raphaël Decoin
AU  - Laura Butruille
AU  - Thomas Defrancq
AU  - Jordan Robert
AU  - Nicolas Destrait
AU  - Augustin Coisne
AU  - Samy Aghezzaf
AU  - Eloise Woitrain
AU  - Zouriatou Gouda
AU  - Sofia Schino
AU  - Cédric Klein
AU  - Patrice Maboudou
AU  - François Brigadeau
AU  - Didier Klug
AU  - Andre Vincentelli
AU  - David Dombrowicz
AU  - Bart Staels
AU  - David Montaigne
AU  - Sandro Ninni
PY  - 2022
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2022.957245
UR  - https://doi.org/10.3389/fendo.2022.957245
ER  -

APA

Decoin, R., Butruille, L., Defrancq, T., Robert, J., Destrait, N., Coisne, A., Aghezzaf, S., Woitrain, E., Gouda, Z., Schino, S., Klein, C., Maboudou, P., Brigadeau, F., Klug, D., Vincentelli, A., Dombrowicz, D., Staels, B., Montaigne, D., & Ninni, S. (2022). High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2022.957245

Source records

crossref · retrieved 2026-09-25T15:43:33.935Z